LimmaTech Biologics: Funding, Investors & Team (Sep 2026)
LimmaTech Biologics AG is a company in the biopharmaceutical industry that is currently in the clinical stage.
LimmaTech Biologics has raised $46.0M across 3 funding rounds on record, the most recent an undisclosed round of $6.5M announced in Feb 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
LimmaTech Biologics Company Profile and Key Stats
Latest funding round on record: Feb 2025.
LimmaTech Biologics Funding Rounds
LimmaTech Biologics raised $36.5M in a Series A announced in Oct 2023.
4 months later, a Series A of $3.0M was announced in Feb 2024.
1 years later, an undisclosed round of $6.5M was announced in Feb 2025.
LimmaTech Biologics Founders and Leadership Team
Contact details for the LimmaTech Biologics team: 1 of 1 has an email address on file.
Start 14-day free trial →LimmaTech Biologics Funding Compared to Other Biotechnology Startups
LimmaTech Biologics' latest round of $6.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like LimmaTech Biologics in Biotechnology and Schlieren
Companies Similar to LimmaTech Biologics
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
At Immitra Bio, we are developing a unique genetic medicine platform that combines two of the most powerful…
compliag is providing agile solutions for regulated industries, including the licencing, manufacturing and…
MoonLake Immunotherapeutics is a biopharmaceutical company in the clinical stage that is developing new…
Isospec Analytics SA is a life science company that aims at simplifying molecular identification. We are…
Cria Technologies reinvents cold-chain transport with high-vacuum insulation technology that offers…
Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections to…
AC Immune is a biopharmaceutical company based in Switzerland that is currently in the clinical stage. They…
AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at…
Combioxin SA is clinical-stage biotech company developing innovative anti-virulence drugs to treat severe…
MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat…
Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the…
LimmaTech Biologics Funding FAQs
What does LimmaTech Biologics do?
LimmaTech Biologics AG is a company in the biopharmaceutical industry that is currently in the clinical stage.
How much funding has LimmaTech Biologics raised?
LimmaTech Biologics has raised $46.0M across 3 rounds on record. The most recent is an undisclosed round of $6.5M announced in Feb 2025.
When did LimmaTech Biologics last raise funding?
LimmaTech Biologics' most recent funding round on record is an undisclosed round of $6.5M, announced in Feb 2025.
Who founded LimmaTech Biologics?
FundedIQ lists Paul Wolfrom (Founder) at LimmaTech Biologics.
Where is LimmaTech Biologics headquartered?
LimmaTech Biologics is based in Schlieren, Zurich, Switzerland.
How many employees does LimmaTech Biologics have?
LimmaTech Biologics is in the 11-50 employee band.
How does LimmaTech Biologics' funding compare to other Biotechnology startups?
LimmaTech Biologics' latest round of $6.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's LimmaTech Biologics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for LimmaTech Biologics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.